Transurethral Plasmakinetic Resection of Prostate to Treat the Benign Prostatic Hyperplasia (Report of 36 Cases)

Objective To investigate the clinical effect of transurethral plasmakinetic resection of prostate (PKRP) in treating benign prostatic hyperplasia. Methods 36 cases with benign prostatic hyperplasia underwent PKRP were analyzed prospectively, then the clinical effect and experience were summarized. Results The mean operation time was 40~120min. All of operations were successful without perforation or transurethral resection syndrome (TURS). The in-dwelling urethral catheter time was 5~10 days. 30 cases were followed-up to 3 months. The IPSS , QOL and Qmax were significantly improved (P0.01). Conclusions It is a safe and effective way of transurethral plasmakinetic resection of prostate in treating the benign prostatic hyperplasia.